S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
Foot Locker Builds Up Another Head of Steam; Gains Imminent
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
Foot Locker Builds Up Another Head of Steam; Gains Imminent
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
Foot Locker Builds Up Another Head of Steam; Gains Imminent
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
3 Value Stocks Too Small For Buffett’s Portfolio
Delta Airline’s Put Option Activity Isn’t Bad News
Disney Stock Catches 3 Upgrades In a Single Week
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
Foot Locker Builds Up Another Head of Steam; Gains Imminent
CVE:ACST

Acasti Pharma (ACST) Stock Price, News & Analysis

C$0.58
+0.01 (+1.75%)
(As of 03/27/2023)
Today's Range
C$0.56
C$0.58
50-Day Range
C$0.58
C$0.58
52-Week Range
C$0.47
C$1.66
Volume
2,450 shs
Average Volume
6,576 shs
Market Capitalization
C$25.87 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
ACST stock logo

About Acasti Pharma Stock (CVE:ACST)

Acasti Pharma Inc., a biopharmaceutical company, engages in the development and commercialization of pharmaceutical products for cardiovascular diseases. It is evaluating strategic partnerships for the clinical development of CaPre. The company was incorporated in 2002 and is headquartered in Laval, Canada.

ACST Stock Price History

ACST Stock News Headlines

Acasti Pharma Inc. Class A
Central Banks Preparing for US Dollar Collapse?
China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.
Will Acasti Pharma (NASDAQ:ACST) Spend Its Cash Wisely?
Acasti Pharma (ACST) Earnings Dates & Reports
Acasti Pharma Inc Class A ACST
Why Acasti Pharma (ACST) Stock Is Exploding Higher
Central Banks Preparing for US Dollar Collapse?
China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.
ACST - Acasti Pharma Inc.
Closing Bell: Acasti Pharma Inc up on Monday (ACST)
Acasti Pharma announces CEO transition
Acasti Pharma Recognizes Rare Disease Day
Acasti Pharma to Present at Q4 Investor Summit
See More Headlines
Receive ACST Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Acasti Pharma and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
32
Year Founded
N/A

Profitability

Net Income
C$-17,250,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$115,000.00
Cash Flow
C$0.93 per share
Book Value
C$2.17 per share

Miscellaneous

Free Float
N/A
Market Cap
C$25.87 million
Optionable
Not Optionable
Beta
1.22
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

  • Ms. Janelle D'Alvise (Age 68)
    Pres, CEO, Corp. Sec. & Director
    Comp: $620.16k
  • Dr. Pierre Lemieux M.D. (Age 58)
    Ph.D., Co-Founder, COO & Chief Scientific Officer
    Comp: $398.75k
  • Mr. Brian D. Ford CPA (Age 64)
    CA, Chief Financial Officer
    Comp: $340.84k
  • Dr. George Kottayil (Age 60)
    Chief Operating Officer of US
    Comp: $160.16k
  • Mr. Prashant Kohli
    Chief Commercial Officer
  • Dr. Yves Lachance Ph.D.
    VP of Quality & Compliance
  • Ms. Christine Pelletier
    Sr. Director of HR

ACST Stock Analysis - Frequently Asked Questions

How have ACST shares performed in 2024?

Acasti Pharma's stock was trading at C$0.58 on January 1st, 2024. Since then, ACST shares have increased by 0.0% and is now trading at C$0.58.
View the best growth stocks for 2024 here
.

What other stocks do shareholders of Acasti Pharma own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Acasti Pharma investors own include Matinas BioPharma (MTNB), Aurora Cannabis (ACB), SCYNEXIS (SCYX), Block (SQ), Nokia Oyj (NOK), Axsome Therapeutics (AXSM), Blink Charging (BLNK), Inovio Pharmaceuticals (INO), Okta (OKTA) and Tesla (TSLA).

How do I buy shares of Acasti Pharma?

Shares of ACST stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

This page (CVE:ACST) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners